Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $33.24M.
ENTERPRISE VALUE (EV)
$33.24M
Nephros, Inc.
Market Cap
$38.25M
Enterprise Value (EV)
$33.24M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Nephros, Inc. (NEPH) | $38.25M | $33.24M |
| Incannex Healthcare Limited (IXHL)vs › | $37.81M | N/A |
| QT Imaging Holdings, Inc. (QTI)vs › | $37.45M | $30.81M |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.77M | $76.47M |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.15M | $37.84M |
| Edesa Biotech, Inc. (EDSA)vs › | $36.41M | $26.08M |
| Veru Inc. (VERU)vs › | $39.80M | $18.61M |
| EUDA Health Holdings Limited (EUDA)vs › | $36.04M | $38.10M |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.94M | $26.61M |
| DocGo Inc. (DCGO)vs › | $35.35M | $36.03M |
Market Cap
$38.25M
Total Debt
$391000.00
Cash
$5.40M
Enterprise Value
$33.24M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
